Association of PPAR Alpha Intron 7 G/C, PPAR Gamma 2 Pro12Ala, and C161T Polymorphisms with Serum Fetuin-A Concentrations

<table class="table-group" id="tab7"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Parameter</td><td class="align_center">Correlation coefficient</td><td class="align_center"><span style="width: 7.83752ptpx;"><svg height="10.2124pt" id="M96" style="vertical-align:-3.42943pt" version="1.1" viewbox="-0.0498162 -6.78297 7.83752 10.2124" width="7.83752pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M570 304C570 398 525 448 414 448C385 448 343 445 312 434L329 511L321 518C297 504 262 482 244 460L233 411C195 397 159 381 128 358L135 332C160 347 189 360 224 373L111 -147C97 -210 84 -218 17 -231L13 -257L254 -247L259 -218L233 -216C183 -212 177 -202 189 -142L218 -1C238 -10 266 -12 283 -12C351 3 429 48 483 105C543 168 570 242 570 304ZM482 289C482 161 380 33 304 33C278 33 248 51 233 69L303 396C326 400 352 403 369 403C428 403 482 380 482 289Z" id="g113-113"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="593" vert-adv-y="593" xpluscharwidth="7.709"></glyph.data></g></svg></span></td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">BMI</td><td class="align_center">0.426</td><td class="align_center">&lt;0.001</td></tr><tr><td class="align_left">Diabetes status (no/yes)</td><td class="align_center">0.102</td><td class="align_center">0.064</td></tr><tr><td class="align_left">HOMA-IR</td><td class="align_center">0.129</td><td class="align_center">0.027</td></tr><tr><td class="align_left">Gender</td><td class="align_center">−0.178</td><td class="align_center">0.008</td></tr><tr><td class="align_left">Postinfarction status (no/yes)</td><td class="align_center">0.098</td><td class="align_center">0.078</td></tr><tr><td class="align_left">PPAR<i>γ</i> Pro/Pro, Pro/Ala, and Ala/Ala</td><td class="align_center">0.050</td><td class="align_center">0.365</td></tr><tr><td class="align_left">PPAR<i>γ</i> Pro allele</td><td class="align_center">0.130</td><td class="align_center">0.018</td></tr><tr><td class="align_left">PPAR<i>γ</i> Ala allele</td><td class="align_center">0.052</td><td class="align_center">0.349</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>BMI: body mass index HOMA-IR: Homeostasis Model Assessment-Insulin Resistance; Spearman correlation.<br/></td></tr></table>

Correlation between serum fetuin-A and investigated parameters <svg height="11.5564pt" id="M95" style="vertical-align:-2.26807pt" version="1.1" viewbox="-0.0498162 -9.28833 49.3933 11.5564" width="49.3933pt" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><g transform="matrix(.013,0,0,-0.013,0,0)"><path d="M300 -147C201 -63 143 98 143 270S200 602 300 686L282 710C136 610 70 450 70 271V270C70 89 136 -72 282 -170L300 -147Z" id="g113-41"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="346" vert-adv-y="346" xpluscharwidth="4.498"></glyph.data></g><g transform="matrix(.013,0,0,-0.013,4.498,0)"><path d="M495 86L479 114C446 82 419 66 409 66C401 66 401 72 406 97C420 166 436 231 453 297C489 435 454 448 428 448C406 448 384 439 354 422C305 394 222 327 161 247H159L183 345C200 415 194 448 173 448C143 448 82 410 23 351L38 325C64 349 95 371 105 371C111 371 116 365 109 336L25 -4L31 -12C50 -4 77 3 107 9C119 69 132 122 145 168C197 254 321 381 370 381C387 381 393 374 378 305L329 95C309 17 320 -12 345 -12C372 -12 430 19 495 86Z" id="g113-111"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="502" vert-adv-y="502" xpluscharwidth="11.024000000000001"></glyph.data></g><g transform="matrix(.013,0,0,-0.013,14.656,0)"><path d="M535 323V373H52V323H535ZM535 138V188H52V138H535Z" id="g117-34"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="587" vert-adv-y="587" xpluscharwidth="22.287"></glyph.data></g><g transform="matrix(.013,0,0,-0.013,25.919,0)"><path d="M285 378C315 398 338 416 353 432C373 451 384 474 384 503C384 579 325 635 236 635H235C182 635 136 610 108 579L65 516L85 496C110 533 150 575 205 575C258 575 300 543 300 481C300 407 232 369 141 339L147 310C163 315 188 321 211 321C268 321 338 284 338 192C338 94 288 40 217 40C160 40 119 68 93 91C85 98 77 97 69 91C60 84 47 71 46 58C44 46 48 35 62 22C75 10 116 -12 162 -12C234 -12 424 62 424 224C424 297 373 359 285 376V378Z" id="g113-52"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="480" vert-adv-y="480" xpluscharwidth="32.159"></glyph.data></g><g transform="matrix(.013,0,0,-0.013,32.159,0)"><path d="M412 140C382 77 369 73 315 73H129L270 222C362 320 402 379 402 466C402 571 322 635 234 635C177 635 130 609 99 576L42 495L64 475C90 514 133 568 201 568C274 568 318 519 318 435C318 349 255 267 193 193C144 135 87 78 32 23V0H405C417 45 427 89 440 131L412 140Z" id="g113-51"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="480" vert-adv-y="480" xpluscharwidth="38.399"></glyph.data></g><g transform="matrix(.013,0,0,-0.013,38.399,0)"><path d="M447 623H65C61 580 56 530 47 475H76C100 541 106 550 172 550H388C308 376 196 170 91 -1L98 -12L172 -2C268 204 360 408 455 611L447 623Z" id="g113-56"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="480" vert-adv-y="480" xpluscharwidth="44.639"></glyph.data></g><g transform="matrix(.013,0,0,-0.013,44.641,0)"><path d="M275 270C275 450 212 609 64 710L45 686C145 604 203 442 203 270S147 -63 45 -147L64 -170C213 -68 275 89 275 270Z" id="g113-42"></path><glyph.data ascent="3473" descent="-2876" horiz-adv-x="346" vert-adv-y="346" xpluscharwidth="49.138999999999996"></glyph.data></g></svg>.

PPAR Research

tab7

Table 7

Table 7: Association of PPAR Alpha Intron 7 G/C, PPAR Gamma 2 Pro12Ala, and C161T Polymorphisms with Serum Fetuin-A Concentrations 